FDA.reportPublic FDA data

BELRAPZO 25 MG/mL Injectable Solution

RxCUI
2178266
RxNorm name
BELRAPZO 25 MG/mL Injectable Solution
Display name
BELRAPZO 25 MG/mL Injectable Solution
Full name
BELRAPZO 25 MG/mL Injectable Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BELRAPZOBENDAMUSTINE HYDROCHLORIDEEagle Pharmaceuticals, Inc9759a4ae-82ca-40cf-9c02-e1cadb21cbdc2024-09-23Warnings, Adverse reactionsExact identifier
rxcui: 2178266

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9759a4ae-82ca-40cf-9c02-e1cadb21cbdcBELRAPZO 25 MG/mL Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [Belrapzo] [SBD] · Belrapzo 25 MG/ML Injectable Solution [SY]311These highlights do not include all the information needed to use BELRAPZO safely and effectively. See full prescribing information for BELRAPZO. BELRAPZO ® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820240923